Skip to Content

Benzocaine / chloroxylenol / hydrocortisone otic Pregnancy and Breastfeeding Warnings

Benzocaine / chloroxylenol / hydrocortisone otic is also known as: MyOxin, Trioxin

Benzocaine / chloroxylenol / hydrocortisone otic Pregnancy Warnings

Benzocaine/chloroxylenol/hydrocortisone otic has not been assigned to a pregnancy category by the FDA. Benzocaine topical has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Chloroxylenol has not been assigned to a pregnancy category by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Hydrocortisone has been assigned to pregnancy category C. Animal studies have revealed evidence of teratogenicity when corticosteroids are administered orally or potent steroids are applied topically. There are no controlled data in human pregnancy. The manufacturer recommends benzocaine/chloroxylenol/hydrocortisone otic not be given during pregnancy.

See references

Benzocaine / chloroxylenol / hydrocortisone otic Breastfeeding Warnings

There are no data on the excretion of benzocaine/chloroxylenol/hydrocortisone otic into human milk.

See references

References for pregnancy information

  1. "Product Information. TriOxin (benzocaine/chloroxylenol/hydrocortisone otic)." Vertical Pharmaceuticals Inc, Scotch Plains, NJ.

References for breastfeeding information

  1. "Product Information. TriOxin (benzocaine/chloroxylenol/hydrocortisone otic)." Vertical Pharmaceuticals Inc, Scotch Plains, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide